Previous Article | Next Article 
Journal of Clinical Microbiology, March 2001, p. 836-843, Vol. 39, No. 3
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.836-843.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rotavirus Strain Diversity in Blantyre, Malawi,
from 1997 to 1999
N. A.
Cunliffe,1,2,3
J.
S.
Gondwe,2
S. M.
Graham,2
B. D. M.
Thindwa,1
W.
Dove,3
R. L.
Broadhead,2
M. E.
Molyneux,1,4 and
C. A.
Hart3,*
Wellcome Trust Research
Laboratories1 and Department of
Paediatrics,2 College of Medicine, University of
Malawi, Blantyre, Malawi, and School of Tropical
Medicine4 and Department of Medical
Microbiology and Genito-Urinary Medicine,3
University of Liverpool, Liverpool, United Kingdom
Received 20 July 2000/Returned for modification 13 November
2000/Accepted 21 December 2000
 |
ABSTRACT |
In a 2-year study of viral gastroenteritis in children in Blantyre,
Malawi, the diversity of rotavirus strains was investigated by using
electropherotyping, reverse transcription-PCR amplification of the VP7
and VP4 genes (G and P genotyping), and nucleotide sequencing. Of 414 rotavirus strains characterized, the following strain types were
identified: P[8], G1 (n = 111; 26.8%); P[6], G8
(n = 110; 26.6%); P[8], G3 (n = 93;
22.5%); P[4], G8 (n = 31; 7.5%); P[8], G4
(n = 21; 5.1%); P[6], G3 (n = 12;
2.9%); P[6], G1 (n = 7; 1.7%); P[6], G9
(n = 3; 0.7%); P[6], G4 (n = 3;
0.7%); P[4], G3 (n = 1; 0.2%); and mixed
(n = 15; 3.6%). While all strains could be assigned a
G type, seven strains (1.7%) remained P nontypeable. The majority of
serotype G8 strains and all serotype G9 strains had short
electropherotype profiles. All remaining typeable strains had long
electropherotypes. Divergent serotype G1 rotaviruses, which contained
multiple base substitutions in the 9T-1 primer binding site, were
commonly identified in the second year of surveillance. Serotype G2 was
not identified. Overall, G8 was the most frequently identified VP7
serotype (n = 144; 34.8%) and P[8] was the most frequently detected VP4 genotype (n = 227; 54.8%).
Partial sequence analysis of the VP4 gene of genotype P[8]
rotaviruses identified three distinct clusters, which predominantly
(but not exclusively) comprised strains belonging to a distinct VP7
serotype (G1, G3, or G4). As a result of mutations in the 1T-1 primer
binding site, strains belonging to each cluster required a separate
primer for efficient typing. One cluster, represented by P[8], G4
strain OP354, was highly divergent from the established Wa and F45 VP4 P[8] lineages. As is the case for some other countries, the diversity of rotaviruses in Malawi implies that rotavirus vaccines in development will need to protect against a wider panel of serotypes than originally envisioned.
 |
INTRODUCTION |
In developing countries severe,
dehydrating diarrhea caused by human rotavirus (HRV) results in an
estimated 500,000 to 870,000 childhood deaths annually (13,
43). The routine implementation of safe and effective rotavirus
vaccine programs in developing countries is expected to reduce
dramatically the high level of mortality attributed to HRV, but the
differing epidemiology of rotavirus in such settings may pose special
challenges to successful vaccine use (6). In particular,
the greater diversity of HRV strains encountered in some developing
countries has implications for the formulation of rotavirus vaccines,
since the original targets of these vaccines were the four most
globally common HRV serotypes, G1 to G4, and some candidate vaccines
were designed to provide serotype-specific (homotypic) protection
(42). Thus, the first licensed vaccine, the tetravalent
rhesus-human reassortant rotavirus (RRV-TV) vaccine, incorporated
strains with these four most-common G-serotypes. The RRV-TV vaccine
proved highly effective in preventing severe rotavirus diarrhea in
infants and young children (3, 35, 49, 52, 53).
Recent evidence suggests that serotypes other than G1 to G4 are
epidemiologically important in some developing countries (e.g., serotype G5 in Brazil [23, 40], serotype G9 in India
[50] and Bangladesh [59], and serotype G8
in Malawi [10]). Furthermore, the recent identification
of serotype G9 rotaviruses in the United States (51), the
United Kingdom (8), Australia (48), and France (4) indicates that some developed countries may
also harbor previously uncommon serotypes. Thus, future HRV vaccines may need to protect against additional serotypes in order to provide broadly effective protection.
Rotaviruses are nonenveloped viruses that possess a segmented
double-stranded RNA (dsRNA) genome, which is enclosed in a
triple-layered protein capsid. The 11 segments can be separated by
using electrophoresis, and two major strain types (short and long
electropherotypes) can be differentiated according to differences in
the relative migration patterns of segments 10 and 11. The middle layer
of the mature rotavirus particle, comprised exclusively of VP6 (encoded by RNA segment 6) specifies rotavirus group and subgroup. Two major
subgroups are recognized among group A HRVs (I and II) but some HRVs
possess both subgroup I and II antigens, and others possess neither
antigen (31). The two outer capsid proteins, VP7 (encoded
by segment 7, 8, or 9) and VP4 (encoded by segment 4), each induce
neutralizing antibodies; thus, a dual typing system classifies HRVs by
VP7 serotype (or G type, since VP7 is a glycoprotein) and VP4 serotype
(or P type, since VP4 is cleaved by proteases). Fourteen VP7 serotypes
have been identified by cross-neutralization studies, which correspond
to their respective genotypes determined by molecular analyses. Eleven
VP4 serotypes have similarly been identified, each of which has been
assigned a "genotype" using molecular analysis (15,
45). Since at least nine further VP4 genotypes have not yet been
assigned a serotype, a complete description of VP4 requires both
molecular and serologic characterization. By convention, VP4 genotype
is enclosed within square brackets (for a review of rotavirus structure
and strain nomenclature, see reference 15).
Field studies of rotavirus strain diversity have traditionally employed
VP7-specific neutralizing monoclonal antibodies in enzyme immunoassays
(EIAs) to detect the common VP7 serotypes in fecal samples
(56). Since a substantial number of strains remain
nontypeable by EIA, and because serologic methods to detect common VP4
serotypes are not routinely available, molecular methods (reverse
transcription-PCR [RT-PCR] and probe hybridization) have been
developed for both VP7 and VP4 typing (17, 18, 24, 27,
39).
Although the genes encoding VP7 and VP4 segregate independently
(32) and numerous combinations of G and P types are
theoretically possible, early studies suggested that four strains
predominate (19). Thus, HRVs with G serotypes G1, G3, and
G4 are typically associated with P[8] VP4 specificity (and possess
long electropherotype profiles and the subgroup II antigen), and
serotype G2 HRVs normally possess the P[4] VP4 genotype (and have
short electropherotype profiles and the subgroup I antigen). However,
recent studies in developing countries that have extensively
characterized large numbers of HRVs have demonstrated much greater
strain diversity than previously appreciated (50, 58, 59).
In Bangladesh, the recognition of multiple combinations of G and P
types and atypical combinations of subgroup and electropherotype,
especially among serotype G9 strains, indicates that genomic
reassortment is a major driving force in the generation of rotavirus
strain diversity (59).
As part of a recently completed 2-year study of viral gastroenteritis
in Blantyre, Malawi, we sought to investigate the diversity of
rotaviruses detected in children with diarrhea (10). We
were especially interested in examining by nucleotide sequencing those strains that failed to be typed with established RT-PCR methods. In so
doing, we gained a more complete understanding of the extent of strain
diversity in this region and enhanced our ability to routinely type
Malawi strains.
 |
MATERIALS AND METHODS |
Fecal specimens.
The study was conducted at the Queen
Elizabeth Central Hospital, Blantyre, Malawi, from July 1997 to June
1999, as previously described (10). Fecal specimens were
collected from children under 5 years old with acute, dehydrating
diarrhea who either were given oral rehydration therapy at the "Under
5" clinic or were admitted to the pediatric wards where they received
oral rehydration therapy and/or intravenous fluid replacement.
Rotavirus testing was performed the same day as specimen collection,
and fecal samples containing rotavirus were then stored at
80°C
until analyzed further.
Rotavirus detection, subgrouping, and electropherotyping.
Rotavirus antigen was detected using the Rotaclone EIA kit
(Meridian Diagnostics, Cincinnati, Ohio). Selected rotaviruses were
subgrouped from stool specimens by EIA, using subgroup-specific monoclonal antibodies (26). Rotavirus dsRNA was extracted
using a guanidine and silica method (18), modified from
that of Boom et al. (5). To determine rotavirus
electropherotype (short or long), the dsRNA was electrophoresed on a
10% polyacrylamide gel and then stained with silver nitrate as
previously described (29). A mixed rotavirus
electropherotype was defined by the presence of a typical group A
rotavirus RNA profile comprising more than 11 RNA segments. Rotavirus
genome profiles that could not be clearly categorized as short or long
electropherotypes were labeled indeterminate.
RT-PCR genotyping.
G and P typing employed nested, multiplex
RT-PCR and used consensus and type-specific primers described
previously (12, 18, 24). Briefly, for G typing, consensus
primers 9con1 and 9con2 were used in a first-round RT-PCR (30 cycles)
to generate a 905-bp VP7 gene fragment; 9con1 was then used in a
second-round PCR (20 cycles) with type-specific primers 9T-1 (G1), 9T-2
(G2), 9T-3P (G3), 9T-4 (G4), and 9T-9B (G9). Since serotype G8 strains were detected frequently in the early part of this study, the G8-specific typing primer MW8 was added to this primer cocktail (10). For P typing, consensus primers con2 and con3 were
used in a first-round RT-PCR (30 cycles) to generate an 877-bp fragment of gene 4; con3 was then used in a second-round PCR (20 cycles) with
type-specific primers 1T-1 (P[8]), 2T-1 (P[4]), 3T-1 (P[6]), 4T-1
(P[9]), and 5T-1 (P[10]). PCR products were resolved by
electrophoresis on a 2% agarose gel, stained with ethidium bromide,
and visualized under UV illumination.
Investigation of nontypeable strains.
As we began typing
year 2 strains it became apparent that, using our existing approach, a
large number were nontypeable with respect to their G and/or P type. In
order to determine whether this reflected genetic variation in primer
binding sites of common strains or uncommon G and P types, nontypeable
strains were further investigated by nucleotide sequencing of
first-round RT-PCR products. The RT-PCR products were purified by using
spin columns (Qiagen, Chatsworth, Calif.) and sequenced by using the
dideoxynucleotide chain termination method with the BigDye sequencing
kit (Applied Biosystems, Inc., Foster City, Calif.) and a model 377 automated DNA sequencer (Applied Biosystems, Inc.). Sequences were
aligned with DNASTAR (Madison, Wis.), and phylogenetic trees were drawn by using PHYLIP (version 3.5c; copyright, J. Felsenstein and the University of Washington) and CLUSTALX (European Molecular Biology Laboratory, Heidelberg, Germany).
For G typing, a large number of strains either gave weak G1 products or
failed to give a detectable product. The full-length VP7 gene of a
nontypeable strain, MW529, was amplified by using the primer pair
beg9-end9 (24), and sequence analysis demonstrated 97.8%
nucleotide identity to the VP7 gene of an Australian serotype G1
rotavirus, G194A (14). Significantly, four base
substitutions were identified in the region of the G1 typing primer
9T-1, compared with the prototype strain Wa from which the primer was
designed (Fig. 1a). Therefore, an
alternative primer (nac9) was designed in the 9T-1 region, which
generated consistently stronger G1-specific products when substituted
for 9T-1 in the second-round PCR (data not shown). Primer nac9 did not
cross-prime with Malawi serotype G3, G4, G8, or G9 strains or with
standard serotype P[4], G2 strain DS-1 (data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
(a) Nucleotide changes in VP7 of Malawi serotype G1
strain MW529 in the 9T-1 region compared to prototype serotype G1
strain Wa. (b) Nucleotide changes in VP4 of Malawi P[8] strains
OP601, MW258, and OP354 in the IT-1 region compared to prototype
genotype P[8] strain KU.
|
|
Since a large number of strains generated weak P[8] products, or
failed to be P typed, con2-con3 gene 4 fragments (representing
nt 11 to
887) of nine P nontypeable strains were sequenced and
compared with
three strains that typed with conventional P[8]
typing primer 1T-1
(Table
1). Where possible, strains were
selected
for sequencing which were collected at different times in the
study, although the choice was limited by a failure to obtain
con2-con3
product for some strains. Four internal primers were
used in addition
to con2 and con3 to sequence each con2-con3 fragment.
Sequence analysis
demonstrated that the 12 strains comprised three
groups of genotype
P[8] viruses, each with multiple (and distinct)
base changes in the
region of the 1T-1 P[8] typing primer, compared
with prototype strain
KU (Fig.
1b). Using sequence data of representative
strains OP601,
MW258, and OP354, three additional P[8] typing
primers were designed
in the 1T-1 region (respectively, nac10,
nac13, and nac25), and these
were added separately to the typing
primer cocktail used in the
second-round PCR. Primers nac10 and
nac25 did not cross-prime with
Malawi genotype P[4] or P[6] strains.
We did observe cross-priming
of primer nac13 with Malawi genotype
P[4] strains; therefore, we
confirmed by nucleotide sequencing
the P[8] specificity of each
strain typed by this primer (data
not shown).
Ethical approval.
The study protocol was approved by the
Malawi National Health Sciences Research Committee. The parents (or
guardians) of each child gave written, informed consent prior to their
child's enrolment in the study.
Nucleotide sequence accession numbers.
Nucleotide sequences
representing con2-con3 fragments of the VP4 gene of the twelve genotype
P[8] strains included in this report have been submitted to the EMBL
Nucleotide Sequence Database. The accession numbers of the
corresponding nucleotide sequences for the following strains are
indicated in parentheses: MW194 (AJ302142), MW258 (AJ302143), MW279
(AJ302144), MW434 (AJ302145), MW670 (AJ302146), OP351 (AJ302147), OP354 (AJ302148), OP371 (AJ302149), OP498 (AJ302150), OP511 (AJ302151), OP530
(AJ302152), and OP601 (AJ302153).
 |
RESULTS |
G and P types.
A total of 414 rotaviruses detected in fecal
specimens of children with diarrhea (221 specimens were collected in
the first year of study) were characterized by RT-PCR genotyping (Table 2; Fig. 2.)
A large number of strains could be typed effectively only after
alternative primer design. For G typing, 97 strains (23.4%), 96 of
which were collected in year 2, were typeable only with the alternative
G1 primer nac9. For P typing, 82 strains (19.8%) failed to be typed
with primer 1T-1 and could be clearly typed only with alternative
P[8] primers nac10, nac13, and nac25: these comprised 47 serotype G1
strains (46 were collected in year 2), 22 serotype G3 strains (7 in
year 2), and 13 serotype G4 strains (8 in year 2).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Temporal distribution of rotavirus strains in Blantyre,
Malawi, from 1997 to 1999. A total of 221 strains were detected in year
1 of the study (1997 to 1998 [shaded bars]), and 193 strains were
detected in year 2 (1998 to 1999 [black bars with white stippling]).
NT, nontypeable.
|
|
After primer design and retesting, a total of 10 different G-P type
combinations were recognized in this collection. Overall,
strain
P[8], G1 was the most frequently detected strain (
n = 111;
26.8%), but was commonly identified only during the second
year,
when it represented 52.3% of strains. Two novel serotype G8
rotaviruses
(strains P[6], G8 and P[4], G8) accounted for 110 (26.6%) and
31 (7.5%) of strains, respectively, and were detected
frequently
in both years of surveillance. Strain P[8], G3 was the
third-most-common
strain overall (
n = 93; 22.5%).
Other strains detected were P[8],
G4 (
n = 21; 5.1%);
P[6], G3 (
n = 12; 2.9%); P[6], G1 (
n = 7; 1.7%);
P[6], G9 (
n = 3; 0.7%); P[6], G4
(
n = 3; 0.7%); and P[4], G3 (
n = 1;
0.2%). Fifteen strains (3.6%) comprised mixed G and/or P
types. While
all strains could be assigned a G type, seven strains
(1.7%) remained
P
nontypeable.
Serotype G8 was the most commonly identified G type (
n = 144; 34.8%) followed by serotypes G1 (
n = 124;
30.0%), G3 (
n = 113;
27.3%), G4 (
n = 25; 6.0%), G9 (
n = 3; 0.7%), and mixed G types
(
n = 5; 1.2%). Serotype G2 was not identified in any
specimen.
The P[8] genotype was the most commonly identified VP4 type
(
n = 227; 54.8%), followed by P[6] (
n = 137; 33.1%) and P[4] (
n = 33; 8.0%). Ten
strains (2.4%) displayed mixed P types, and seven
strains (1.7%)
could not be P
typed.
Electropherotypes and subgroups.
An electropherotype could be
assigned to 385 (93%) of the strains (Table 2). These comprised 250 (60.4%) long profiles, 133 (32.1%) short profiles, and two (0.5%)
mixed profiles. No evidence of rearrangement of genome segments was
identified. The short electropherotype profiles consisted of the
majority of serotype G8 strains and each of three serotype G9 strains.
Two P[6], G8 strains possessed long electropherotypes. All remaining
typeable strains had long electropherotypes. Each strain of a
representative sample of short electropherotype viruses, including
serotype G8 and G9 strains, possessed subgroup I specificity (data not
shown). Sufficient fecal material remained for subgrouping of one long electropherotype, P[6], G8 strain, which belonged to subgroup II.
Finally, each of the three representative members of the long electropherotype, divergent P[8] strains (OP601, MW258 and OP354), belonged to subgroup II.
Phylogenetic analyses.
Phylogenetic analysis of the complete
326-amino-acid (-aa) VP7 protein of serotype G1 strain MW529 confirmed
that it belonged to lineage I of serotype G1 HRVs (34)
(data not shown).
The presence of three distinct clusters of P[8] strains was suggested
by the typing characteristics of strains that failed
to be typed with
the conventional P[8] primer 1T-1. Each alternative
P[8] typing
primer (nac10, nac13, and nac25) effectively amplified
the majority of
strains with the same G-type as the strain from
which the primer was
designed but generally failed to give product
with strains of a
different G type (data not shown). However,
six strains (comprising a
single serotype G3 strain and five serotype
G4 strains), were P typed
using an alternative primer designed
from a strain of a different G
type. The con2-con3 RT-PCR products
of two such strains, serotype G3
strain OP498 (typed by nac10)
and serotype G4 strain OP511 (typed by
nac13), were therefore
sequenced and examined
phylogenetically.
Phylogenetic analysis of partial VP4 sequences of 12 Malawi P[8]
strains confirmed the presence of three clusters that each
comprised
strains typed by a distinct alternative primer (or by
1T-1) and
predominantly (but not exclusively) comprised strains
belonging to a
distinct G type (G1, G3, or G4) (Fig.
3). The three
groups are
represented respectively by prototype strains OP601
(P[8], G1), MW258
(P[8], G3), and the highly divergent strain
OP354 (P[8], G4).
Malawi strains within a cluster shared greater
than 98% nucleotide and
amino acid identity. The VP4 sequences
of serotype G3 strain OP498 and
serotype G4 strain OP511 clustered
with serotype G1 (OP601-like) and
serotype G3 (MW258-like) rotaviruses,
respectively (Fig.
3).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
Neighbor-joining nucleotide distance tree for residues
representing nucleotides 11 to 887 of the VP4 gene of the indicated
genotype P[8] strains. The G type is indicated for each strain.
Sequences were aligned by using CLUSTALX and analyzed by using the
DNADIST and NEIGHBOR programs in PHYLIP. The accession numbers of the
reference strains used in this analysis were L34161 (for Wa)
(46), U30716 (for F45) (37), and M21014 (for
KU) (57).
|
|
The VP4 gene fragments of three serotype G4 strains (represented by
strain OP354), shared 99.5% nucleotide identity and 100%
amino acid
identity. Using >89% amino acid identity as the cutoff
for strains of
the same genotype (
21), OP354-like strains were
just
classified within the P[8] genotype and displayed 89.7, 90.0,
and
90.4% amino acid identities to standard genotype P[8] strains
Wa,
KU, and F45, respectively. They were also quite distantly
related to
Malawi P[8] strains that comprised the remaining two
clusters (88.6 to 89.2% nucleotide identity and 90.4 to 91.4%
amino acid identity to
OP601-like strains and 88.3 to 89.2% nucleotide
identity and 90.7 to
91.4% amino acid identity to MW258-like strains).
Phylogenetic
analysis (Fig.
3) confirmed that OP354-like strains
form a cluster
which is distinct from the two established VP4
lineages, represented by
strains Wa and F45 (
25). Gouvea et
al. (
25)
described 11 aa between aa 27 and 240 which are conserved
within the Wa
lineage but are distinct from the F45 lineage. At
these sites,
OP354-like strains possess Wa-like amino acids at
four positions,
F45-like amino acids at five positions, and an
amino acid typical of
neither lineage at two positions (Fig.
4).
Thus, based on partial sequence
analysis of the VP4 gene, three
serotype G4 Malawi strains as typified
by OP354 appear to comprise
a further, highly divergent P[8] lineage.

View larger version (6K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of conserved amino acids between residues 27 and 240 of VP4 of OP354-like strains compared to Wa-like and F45-like
strains. (The data for Wa-like and F45-like strains are from a report
by Gouvea et al. [25].)
|
|
 |
DISCUSSION |
This study has described the diversity of rotavirus strains in
Blantyre from 1997 to 1999. By using nested RT-PCR amplification of VP7
and VP4 gene fragments, and by extensive investigation of rotaviruses
that failed to be typed by established methods, we were able to fully
type 407 of 414 (98.3%) strains. The design of additional primers
enabled the effective amplification of all serotype G8 rotaviruses, all
divergent serotype G1 strains, and many divergent genotype P[8]
strains. Furthermore, the thorough investigation of nontypeable strains
by nucleotide sequencing described the degree of divergence among these
strains and their relationships to published HRV strains.
A notable finding was the marked contrast in strain distributions
between the first and second years of the study, especially the
detection in the second year of large numbers of divergent P[8], G1
strains. Although poorly understood, sudden changes in prevalent
rotavirus serotypes are well recognized (36), and established strain typing methods may need modifying to take account not only of geographic diversity among HRVs but of temporal changes as
well. In this regard, the type-specific primers currently used in
RT-PCR typing methods were designed up to 10 years ago based on as few
as one sequence for each G or P type, because only limited sequence
data were available at that time (12, 18, 24, 27). The
large amount of sequence information now available in the database,
combined with the relative ease of automated compared with radioactive
sequencing, should encourage the design of updated primers because of
the high degree of sequence variation that has been found in this and
other recent studies (33). The importance of rigorously
evaluating the specificity of newly designed primers was emphasized in
the present study by the finding of cross-priming between the
alternative P[8] primer nac13 and local genotype P[4] strains. The
close genetic relationship between P[8] and P[4] strains makes
cross-priming between these genotypes more likely.
The VP7 serotypes G1 to G4 together account for approximately 80% of
global strains (19, 38) but represent only 63.3% of the
collection used in this study. The absence of serotype G2, combined
with the high prevalence of serotype G8, largely accounts for the
relative underrepresentation of the four globally common G types in
Malawi. We have previously described the frequent detection of serotype
G8 rotaviruses in Malawi (10), which may represent
human-bovine reassortant viruses (11). Serotype G8 was
detected throughout the present study and was the most commonly identified G type in this collection, representing 34.8% of all strains. Most serotype G8 strains were of the short electropherotype. We did not identify any supershort electropherotype profiles
characteristic of the prototype human serotype G8 rotavirus 69M
isolated in Southeast Asia (28). However, two P[6], G8
strains of long electropherotype were recognized (one strain examined
belongs to subgroup II), which are more typical of serotype G8
rotaviruses detected in Europe (20). Serotype G8 may be
especially common in Africa, since several recent reports from African
countries other than Malawi have documented the presence of this
serotype. These countries include Nigeria (1), Egypt
(30), Kenya (44), South Africa (55), and Guinea-Bissau (16).
Serotype G1 is the most common global serotype and was the second most
frequently detected G-type in this study, encompassing 30% of strains.
The VP7 protein of a representative serotype G1 strain, MW529, was
closely related to several recent Australian serotype G1 strains
described by Diwakarla et al. (14) and was demonstrated by
phylogenetic analysis to belong to lineage I of serotype G1 strains
(34). Serotypes G3 and G4 are also globally common strains
and respectively accounted for 27.3 and 6.0% of strains in our
collection. Serotype G9, which appears to be an emerging global
serotype (4, 8, 48, 50, 51, 59), was detected in only
0.7% of strains. A surprising finding was the total absence of
serotype G2 rotaviruses, since this is the most commonly identified
serotype in some studies and represents >10% of global strains
(19, 38). The lack of archived stool collections from
children in Malawi renders it difficult to ascertain if serotype G2 has
previously circulated in the country, but this serotype has recently
been described in a study of a neighboring country, Zambia
(54).
The globally most prevalent P[8] genotype was the most commonly
detected VP4 type in the present study (54.8% of all strains). However, sequence analysis of the VP8* subunit of VP4 identified extensive diversity among these strains, with three distinct clusters of strains that segregated largely according to G type. Because of this
diversity, three P[8] typing primers were required, in addition to
1T-1, to successfully type the majority of P[8] strains. Sequence
diversity within the VP8* subunit of P[8] strains necessitated the
design of a degenerate version of the 1T-1 typing primer in a recent
study from the United Kingdom (33). The observation of
clusters of P[8] strains that, in general, grouped according to VP7
serotype, contradicts previous observations that found no such
association (33, 41). Although VP7 and VP4 segregate independently, it is likely that the three groups of P[8] strains that possess G1, G3, or G4 VP7 specificity (represented, respectively, by strains OP601, MW258, and OP354), represent the most stable VP7-VP4
combinations, and the viruses are therefore more likely to persist in
nature. Some strains were detected, however, that did not fall into one
of the three clusters. For example, the VP4 sequence of a serotype G3
strain (OP498) clustered with serotype G1 (OP601-like) strains, and the
VP4 sequence of a serotype G4 strain (OP511) clustered with serotype G3
(MW258-like) strains. Such strains are likely to be VP7 or VP4
reassortants between strains belonging to separate clusters.
Of particular interest is the highly divergent cluster of closely
related P[8] strains represented by strain OP354. Overall sequence
identity, comparison of conserved amino acid residues with Wa and F45
lineages, and phylogenetic analysis indicate that OP354-like strains
form a distinct lineage. Using shorter VP8* sequences (encompassing
nucleotides 250 to 624), Maunula and von Bonsdorff (41)
could define three P[8] lineages, P[8]-1, P[8]-2, and P[8]-3.
Furthermore, by examining amino acid residues between positions 121 and
135, 4 aa (at positions 121, 125, 131, and 135) were strictly conserved
within lineages. These P[8] lineage signature motifs were identified
as ISSN, VNRD, and INRN, respectively, for lineages P[8]-1, P[8]-2,
and P[8]-3 (41). While OP354-like strains group
phylogenetically (using short sequences) with strains representing
lineage P[8]-3 described by Maunula and von Bonsdorff (data not
shown), the signature motif (ISRN) differs from the lineage-defining
motif for P[8]-3 (Fig. 4). Therefore, we are currently examining
further the complete VP4 (including VP8* and VP5* subunits) of OP354 to
more fully assess its genetic and antigenic relationship to standard
serotype P1A[8] strains. Although VP7 is the surface protein
represented in most current vaccines, VP4 may also be important in
inducing protective immunity (60), and rotavirus vaccines
containing antigen representing the most common P serotype, P1A[8],
have undergone evaluation in field trials (7). Since
previous studies have documented greater antigenic variability in VP4
than was indicated by genomic typing methods (47), the
diversity of VP4 in Malawi may be even greater than is apparent by the
genomic analysis presented here. This may be relevant to future HRV
vaccine strategies in Malawi.
Because of their recognized association with asymptomatic neonatal
infections, HRVs with the VP4 P[6] genotype were thought to be
attenuated and unlikely to cause diarrhea (22). Our
finding of large numbers of P[6] strains among children with diarrhea (this genotype was detected in 33.1% of children) confirms similar recent reports from other countries (2, 4, 8, 50, 51, 58,
59).
This study extends our understanding of the tremendous diversity of HRV
strains in some countries and has direct implications for the
formulation of effective rotavirus vaccines. Strain surveillance is
important in countries such as Malawi to monitor the prevalent rotavirus serotypes before future rotavirus vaccine programs are instated and to enable detection of new serotypes that could emerge as
a consequence of widespread vaccine use. Reduction of the huge burden
of disease caused by rotavirus in Africa by the successful introduction
of rotavirus vaccines would make such efforts worthwhile (9).
 |
ACKNOWLEDGMENTS |
Nigel Cunliffe is the recipient of a Wellcome Trust Research
Training Fellowship in Clinical Tropical Medicine (grant 049485/Z/96).
We thank the staff of the Department of Paediatrics, College of
Medicine, for their support during the course of this work; Ida
Nkhonjera and Constance Magola for collecting samples; and the parents
and guardians of the children involved in this study for their willing
participation. We thank Jon Gentsch for providing laboratory support
throughout this project and for his critical review of the manuscript.
We also thank Roger Glass and Joseph Bresee for helpful comments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Genito-Urinary Medicine, University of
Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, United
Kingdom. Phone: 44-151-706-4381. Fax: 44-151-706-5805. E-mail:
cahmm{at}liv.ac.uk.
 |
REFERENCES |
| 1.
|
Adah, M. I.,
A. Rohwedder,
O. D. Olaleye, and H. Werchau.
1997.
Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3' end of the primer binding site.
Arch. Virol.
142:1881-1887[CrossRef][Medline].
|
| 2.
|
Adah, M. I.,
A. Rohwedder,
O. D. Olaleye,
O. A. Durojaiye, and H. Werchau.
1997.
Further characterization of field strains of rotavirus from Nigeria. VP4 genotype P6 most frequently identified among symptomatically infected children.
J. Trop. Pediatr.
43:267-274[Abstract/Free Full Text].
|
| 3.
|
Bernstein, D. I.,
R. I. Glass,
G. Rodgers,
B. L. Davidson, and D. A. Sack.
1995.
Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children.
JAMA
273:1191-1196[Abstract/Free Full Text].
|
| 4.
|
Bon, F.,
C. Fromantin,
S. Aho,
P. Pothier,
E. Kohli, and the AZAY group.
2000.
G and P genotyping of rotavirus strains circulating in France over a three-year period: detection of G9 and P[6] strains at low frequencies.
J. Clin. Microbiol.
38:1681-1683[Abstract/Free Full Text].
|
| 5.
|
Boom, R.,
C. J. A. Sol,
M. M. M. Salimans,
C. L. Jansen,
P. M. E. Wertheim-Van Dillen, and J. Van Der Noordaa.
1990.
Rapid and simple method for purification of nucleic acids.
J. Clin. Microbiol.
28:495-503[Abstract/Free Full Text].
|
| 6.
|
Bresee, J. S.,
R. I. Glass,
B. Ivanoff, and J. R. Gentsch.
1999.
Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries.
Vaccine
17:2207-2222[CrossRef][Medline].
|
| 7.
|
Clark, H. F.,
P. A. Offit,
R. W. Ellis,
J. J. Eiden,
D. Krah,
A. R. Shaw,
M. Pichichero,
J. J. Treanor,
F. E. Borian,
L. M. Bell, and S. A. Plotkin.
1996.
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.
J. Infect. Dis.
174:S73-S80.
|
| 8.
|
Cubitt, W. D.,
A. D. Steele, and M. Iturriza.
2000.
Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6].
J. Med. Virol.
61:150-154[CrossRef][Medline].
|
| 9.
|
Cunliffe, N. A.,
P. E. Kilgore,
J. S. Bresee,
A. D. Steele,
N. Luo,
C. A. Hart, and R. I. Glass.
1998.
Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization.
Bull. W. H. O.
76:525-537[Medline].
|
| 10.
|
Cunliffe, N. A.,
J. S. Gondwe,
R. L. Broadhead,
M. E. Molyneux,
P. A. Woods,
J. S. Bresee,
R. I. Glass,
J. R. Gentsch, and C. A. Hart.
1999.
Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains.
J. Med. Virol.
57:308-312[CrossRef][Medline].
|
| 11.
|
Cunliffe, N. A.,
J. R. Gentsch,
C. D. Kirkwood,
J. S. Gondwe,
W. Dove,
O. Nakagomi,
T. Nakagomi,
Y. Hoshino,
J. S. Bresee,
R. I. Glass,
M. E. Molyneux, and C. A. Hart.
2000.
Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi.
Virology
274:309-320[CrossRef][Medline].
|
| 12.
|
Das, B. K.,
J. R. Gentsch,
H. G. Cicirello,
P. A. Woods,
A. Gupta,
M. Ramachandran,
R. Kumar,
M. K. Bhan, and R. I. Glass.
1994.
Characterization of rotavirus strains from newborns in New Delhi, India.
J. Clin. Microbiol.
32:1820-1822[Abstract/Free Full Text].
|
| 13.
|
De Zoysa, I., and R. G. Feachem.
1985.
Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization.
Bull. W. H. O.
63:569-583[Medline].
|
| 14.
|
Diwakarla, C. S., and E. A. Palombo.
1999.
Genetic and antigenic variation of capsid protein VP7 of serotype G1 human rotavirus isolates.
J. Gen. Virol.
80:341-344[Abstract].
|
| 15.
|
Estes, M. K.
1996.
Rotaviruses and their replication, p. 1625-1655.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Press, Philadelphia, Pa.
|
| 16.
|
Fischer, T. K.,
H. Steinsland,
K. Molbak,
R. Ca,
J. R. Gentsch,
P. Valentiner-Branth,
P. Aaby, and H. Sommerfelt.
2000.
Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa.
J. Clin. Microbiol.
38:264-267[Abstract/Free Full Text].
|
| 17.
|
Flores, J.,
K. Y. Green,
D. Garcia,
J. Sears,
I. Perez-Schael,
L. F. Avendano,
W. B. Rodriguez,
K. Taniguchi,
S. Urasawa, and A. Z. Kapikian.
1989.
Dot hybridization assay for distinction of rotavirus serotypes.
J. Clin. Microbiol.
27:29-34[Abstract/Free Full Text].
|
| 18.
|
Gentsch, J. R.,
R. I. Glass,
P. Woods,
V. Gouvea,
M. Gorziglia,
J. Flores,
B. K. Das, and M. K. Bhan.
1992.
Identification of group A rotavirus gene 4 types by polymerase chain reaction.
J. Clin. Microbiol.
30:1365-1373[Abstract/Free Full Text].
|
| 19.
|
Gentsch, J. R.,
P. A. Woods,
M. Ramachandran,
B. K. Das,
J. P. Leite,
A. Alfieri,
R. Kumar,
M. K. Bhan, and R. I. Glass.
1996.
Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development.
J. Infect. Dis.
174:S30-S36.
|
| 20.
|
Gerna, G.,
A. Sarasini,
L. Zentilin,
A. Di Matteo,
P. Miranda,
M. Parea,
M. Battaglia, and G. Milanesi.
1990.
Isolation in Europe of 69M-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype.
Arch. Virol.
112:27-40[CrossRef][Medline].
|
| 21.
|
Gorziglia, M.,
G. Larralde,
A. Z. Kapikian, and R. M. Chanock.
1990.
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
Proc. Natl. Acad. Sci. USA
87:7155-7159[Abstract/Free Full Text].
|
| 22.
|
Gorziglia, M.,
K. Green,
K. Nishikawa,
K. Taniguchi,
R. Jones,
A. Z. Kapikian, and R. M. Chanock.
1988.
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections.
J. Virol.
62:2978-2984[Abstract/Free Full Text].
|
| 23.
|
Gouvea, V.,
L. de Castro,
M. do C. Timenetsky,
H. Greenberg, and N. Santos.
1994.
Rotavirus serotype G5 associated with diarrhea in Brazilian children.
J. Clin. Microbiol.
32:1408-1409[Abstract/Free Full Text].
|
| 24.
|
Gouvea, V.,
R. I. Glass,
P. Woods,
K. Taniguchi,
H. F. Clark,
B. Forrester, and Z. Y. Fang.
1990.
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.
J. Clin. Microbiol.
28:276-282[Abstract/Free Full Text].
|
| 25.
|
Gouvea, V.,
R. C. C. Lima,
R. E. Linhares,
H. F. Clark,
C. M. Nosawa, and N. Santos.
1999.
Identification of two lineages (WA-like and F45-like) within the major rotavirus genotype P[8].
Virus Res.
59:141-147[CrossRef][Medline].
|
| 26.
|
Greenberg, H.,
V. McAuliffe,
J. Valdesuso,
R. Wyatt,
J. Flores,
A. Kalica,
Y. Hoshino, and N. Singh.
1983.
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies.
Infect. Immun.
39:91-99[Abstract/Free Full Text].
|
| 27.
|
Gunasena, S.,
O. Nakagomi,
Y. Isegawa,
E. Kaga,
T. Nakagomi,
A. D. Steele,
J. Flores, and S. Ueda.
1993.
Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea.
J. Clin. Microbiol.
31:2195-2197[Abstract/Free Full Text].
|
| 28.
|
Hasegawa, A.,
S. Inouye,
S. Matsuno,
K. Yamaoka,
R. Eko, and W. Suharyono.
1984.
Isolation of human rotaviruses with a distinct RNA electrophoretic pattern from Indonesia.
Microbiol. Immunol.
28:719-722[Medline].
|
| 29.
|
Herring, A. J.,
N. F. Inglis,
C. K. Ojeh,
D. R. Snodgrass, and J. D. Menzies.
1982.
Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels.
J. Clin. Microbiol.
16:473-477[Abstract/Free Full Text].
|
| 30.
|
Holmes, J. L.,
C. D. Kirkwood,
G. Gerna,
J. D. Clemens,
M. R. Rao,
A. B. Naficy,
R. Abu-Elyazeed,
S. J. Savarino,
R. I. Glass, and J. R. Gentsch.
1999.
Characterization of unusual G8 rotavirus strains isolated from Egyptian children.
Arch. Virol.
144:1381-1396[CrossRef][Medline].
|
| 31.
|
Hoshino, Y., and A. Z. Kapikian.
1994.
Rotavirus antigens.
Curr. Top. Microbiol. Immunol.
185:179-227[Medline].
|
| 32.
|
Hoshino, Y.,
M. M. Sereno,
K. Midthun,
J. Flores,
A. Z. Kapikian, and R. M. Chanock.
1985.
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.
Proc. Natl. Acad. Sci. USA
82:8701-8704[Abstract/Free Full Text].
|
| 33.
|
Iturriza-Gomara, M.,
J. Green,
D. W. G. Brown,
U. Desselberger, and J. J. Gray.
2000.
Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping.
J. Clin. Microbiol.
38:898-901[Abstract/Free Full Text].
|
| 34.
|
Jin, Q.,
R. L. Ward,
D. R. Knowlton,
Y. B. Gabbay,
A. C. Linhares,
R. Rappaport,
P. A. Woods,
R. I. Glass, and J. R. Gentsch.
1996.
Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
Arch. Virol.
141:2057-2076[CrossRef][Medline].
|
| 35.
|
Joensuu, J.,
E. Koskenniemi,
X.-L. Pang, and T. Vesikari.
1997.
Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Lancet
350:1205-1209[CrossRef][Medline].
|
| 36.
|
Kapikian, A. Z., and R. M. Chanock.
1996.
Rotaviruses, p. 1657-1708.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Press, Philadelphia, Pa.
|
| 37.
|
Kirkwood, C. D.,
R. F. Bishop, and B. S. Coulson.
1996.
Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.
Arch. Virol.
141:587-600[CrossRef][Medline].
|
| 38.
|
Koshimura, Y.,
T. Nakagomi, and O. Nakagomi.
2000.
The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: a 10-year survey (1987-1996) in Japan with a review of globally collected data.
Microbiol. Immunol.
44:499-510[Medline].
|
| 39.
|
Larralde, G., and J. Flores.
1990.
Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes.
Virology
179:469-473[CrossRef][Medline].
|
| 40.
|
Leite, J. P. G.,
A. A. Alfieri,
P. A. Woods,
R. I. Glass, and J. R. Gentsch.
1996.
Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis.
Arch. Virol.
141:2365-2374[CrossRef][Medline].
|
| 41.
|
Maunula, L., and C.-H. von Bonsdorff.
1998.
Short sequences define genetic lineages: phylogenetic analysis of group A rotaviruses based on partial sequences of genome segments 4 and 9.
J. Gen. Virol.
79:321-332[Abstract].
|
| 42.
|
Midthun, K., and A. Z. Kapikian.
1996.
Rotavirus vaccines: an overview.
Clin. Microbiol. Rev.
9:423-434[Abstract].
|
| 43.
|
Miller, M. A., and L. McCann.
2000.
Policy analysis of the use of hepatitis B, Haemophilus influenzae type B-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
Health Econ.
9:19-35[CrossRef][Medline].
|
| 44.
|
Nakata, S.,
Z. Gatheru,
S. Ukae,
N. Adachi,
N. Kobayashi,
S. Honma,
J. Muli,
P. Ogaja,
J. Nyangao,
E. Kiplagat,
P. M. Tukei, and S. Chiba.
1999.
Epidemiological study of the G serotype distribution of group A rotaviruses in Kenya from 1991 to 1994.
J. Med. Virol.
58:296-303[CrossRef][Medline].
|
| 45.
|
Okada, J.,
T. Urasawa,
N. Kobayashi,
K. Taniguchi,
A. Hasegawa,
K. Mise, and S. Urasawa.
2000.
New P serotype of group A human rotavirus closely related to that of a porcine rotavirus.
J. Med. Virol.
60:63-69[CrossRef][Medline].
|
| 46.
|
Padilla-Noriega, L.,
S. J. Dunn,
S. Lopez,
H. B. Greenberg, and C. F. Arias.
1995.
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.
Virology
206:148-154[CrossRef][Medline].
|
| 47.
|
Padilla-Noriega, L.,
M. Mendez-Toss,
G. Menchaca,
J. F. Contreras,
P. Romero-Guido,
F. I. Puerto,
H. Guiscafre,
F. Mota,
I. Herrera,
R. Cedillo,
O. Munoz,
J. Calva,
M. de Lourdes Guerrero,
B. S. Coulson,
H. B. Greenberg,
S. Lopez, and C. F. Arias.
1998.
Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.
J. Clin. Microbiol.
36:1688-1692[Abstract/Free Full Text].
|
| 48.
|
Palombo, E. A.,
P. J. Masendycz,
H. C. Bugg,
N. Bogdanovic-Sakran,
G. L. Barnes, and R. F. Bishop.
2000.
Emergence of serotype G9 human rotaviruses in Australia.
J. Clin. Microbiol.
38:1305-1306[Free Full Text].
|
| 49.
|
Perez-Schael, I.,
M. J. Guntinas,
M. Perez,
V. Pagone,
A. M. Rojas,
R. Gonzalez,
W. Cunto,
Y. Hoshino, and A. Z. Kapikian.
1997.
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
N. Engl. J. Med.
337:1181-1187[Abstract/Free Full Text].
|
| 50.
|
Ramachandran, M.,
B. K. Das,
A. Vij,
R. Kumar,
S. S. Bhambal,
N. Kesari,
H. Rawat,
L. Bahl,
S. Thakur,
P. A. Woods,
R. I. Glass,
M. K. Bhan, and J. R. Gentsch.
1996.
Unusual diversity of human rotavirus G and P genotypes in India.
J. Clin. Microbiol.
34:436-439[Abstract].
|
| 51.
|
Ramachandran, M.,
J. R. Gentsch,
U. D. Parashar,
S. Jin,
P. A. Woods,
J. L. Holmes,
C. D. Kirkwood,
R. F. Bishop,
H. B. Greenberg,
S. Urasawa,
G. Gerna,
B. S. Coulson,
K. Taniguchi,
J. S. Bresee,
R. I. Glass, and The National Rotavirus Strain Surveillance System Collaborating Laboratories.
1998.
Detection and characterization of novel rotavirus strains in the United States.
J. Clin. Microbiol.
36:3223-3229[Abstract/Free Full Text].
|
| 52.
|
Rennels, M. B.,
R. I. Glass,
P. H. Dennehy,
D. I. Bernstein,
M. E. Pichichero,
E. T. Zito,
M. E. Mack,
B. L. Davidson, and A. Z. Kapikian.
1996.
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the national multicenter trial.
Pediatrics
97:7-13[Abstract/Free Full Text].
|
| 53.
|
Santosham, M.,
L. H. Moulton,
R. Reid,
J. Croll,
R. Weatherholt,
R. Ward,
J. Forro,
E. Zito,
M. Mack,
G. Brenneman, and B. L. Davidson.
1997.
Efficacy and safety of high dose rhesus human reassortant rotavirus vaccine in Native American populations.
J. Pediatr.
131:632-638[CrossRef][Medline].
|
| 54.
|
Steele, A. D.,
F. C. Kasolo,
P. Bos,
I. Peenze,
H. Oshitani, and E. Mpabalwani.
1998.
Characterization of VP6 subgroup, VP7 and VP4 genotype of rotavirus strains in Lusaka, Zambia.
Ann. Trop. Pediatr.
18:111-116[Medline].
|
| 55.
|
Steele, A. D.,
S. P. Parker,
I. Peenze,
C. T. Pager,
M. B. Taylor, and W. D. Cubitt.
1999.
Comparative studies of human rotavirus serotype G8 strains recovered in South Africa and the United Kingdom.
J. Gen. Virol.
80:3029-3034[Abstract/Free Full Text].
|
| 56.
|
Taniguchi, K.,
T. Urasawa,
Y. Morita,
H. B. Greenberg, and S. Urasawa.
1987.
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.
J. Infect. Dis.
155:1159-1166[Medline].
|
| 57.
|
Taniguchi, K.,
W. L. Maloy,
K. Nishikawa,
K. Y. Green,
Y. Hoshino,
S. Urasawa,
A. Z. Kapikian,
R. M. Chanock, and M. Gorziglia.
1988.
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
J. Virol.
62:2421-2426[Abstract/Free Full Text].
|
| 58.
|
Timenetsky, M. do C.,
N. Santos, and V. Gouvea.
1994.
Survey of rotavirus G and P types associated with human gastroenteritis in Sao Paulo, Brazil, from 1986 to 1992.
J. Clin. Microbiol.
32:2622-2624[Abstract/Free Full Text].
|
| 59.
|
Unicomb, L. E.,
G. Podder,
J. R. Gentsch,
P. A. Woods,
K. Z. Hasan,
A. S. G. Faruque,
M. J. Albert, and R. I. Glass.
1999.
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.
J. Clin. Microbiol.
37:1885-1891[Abstract/Free Full Text].
|
| 60.
|
Ward, R. L.,
M. M. McNeal,
D. S. Sander,
H. B. Greenberg, and D. I. Bernstein.
1993.
Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.
J. Virol.
67:464-468[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, March 2001, p. 836-843, Vol. 39, No. 3
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.836-843.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Matthijnssens, J., Potgieter, C. A., Ciarlet, M., Parreno, V., Martella, V., Banyai, K., Garaicoechea, L., Palombo, E. A., Novo, L., Zeller, M., Arista, S., Gerna, G., Rahman, M., Van Ranst, M.
(2009). Are Human P[14] Rotavirus Strains the Result of Interspecies Transmissions from Sheep or Other Ungulates That Belong to the Mammalian Order Artiodactyla?. J. Virol.
83: 2917-2929
[Abstract]
[Full Text]
-
Bourdett-Stanziola, L., Jimenez, C., Ortega-Barria, E.
(2008). Diversity of Human Rotavirus G and P Genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg
79: 921-924
[Abstract]
[Full Text]
-
Kheyami, A. M., Nakagomi, T., Nakagomi, O., Dove, W., Hart, C. A., Cunliffe, N. A.
(2008). Molecular Epidemiology of Rotavirus Diarrhea among Children in Saudi Arabia: First Detection of G9 and G12 Strains. J. Clin. Microbiol.
46: 1185-1191
[Abstract]
[Full Text]
-
Sharma, S., Ray, P., Gentsch, J. R., Glass, R. I., Kalra, V., Bhan, M. K.
(2008). Emergence of G12 Rotavirus Strains in Delhi, India, in 2000 to 2007. J. Clin. Microbiol.
46: 1343-1348
[Abstract]
[Full Text]
-
Tcheremenskaia, O., Marucci, G., De Petris, S., Ruggeri, F. M., Dovecar, D., Sternak, S. L., Matyasova, I., Dhimolea, M. K., Mladenova, Z., Fiore, L., and the Rotavirus Study Group,
(2007). Molecular Epidemiology of Rotavirus in Central and Southeastern Europe. J. Clin. Microbiol.
45: 2197-2204
[Abstract]
[Full Text]
-
Arista, S., Giammanco, G. M., De Grazia, S., Ramirez, S., Lo Biundo, C., Colomba, C., Cascio, A., Martella, V.
(2006). Heterogeneity and Temporal Dynamics of Evolution of G1 Human Rotaviruses in a Settled Population. J. Virol.
80: 10724-10733
[Abstract]
[Full Text]
-
Uchida, R., Pandey, B. D., Sherchand, J. B., Ahmed, K., Yokoo, M., Nakagomi, T., Cuevas, L. E., Cunliffe, N. A., Hart, C. A., Nakagomi, O.
(2006). Molecular Epidemiology of Rotavirus Diarrhea among Children and Adults in Nepal: Detection of G12 Strains with P[6] or P[8] and a G11P[25] Strain.. J. Clin. Microbiol.
44: 3499-3505
[Abstract]
[Full Text]
-
van Zyl, W. B., Page, N. A., Grabow, W. O. K., Steele, A. D., Taylor, M. B.
(2006). Molecular epidemiology of group a rotaviruses in water sources and selected raw vegetables in southern Africa.. Appl. Environ. Microbiol.
72: 4554-4560
[Abstract]
[Full Text]
-
Fischer, T. K., Eugen-Olsen, J., Pedersen, A. G., Molbak, K., Bottiger, B., Rostgaard, K., Nielsen, N. M.
(2005). Characterization of Rotavirus Strains in a Danish Population: High Frequency of Mixed Infections and Diversity within the VP4 Gene of P[8] Strains. J. Clin. Microbiol.
43: 1099-1104
[Abstract]
[Full Text]
-
Arista, S., Giammanco, G. M., De Grazia, S., Colomba, C., Martella, V.
(2005). Genetic Variability among Serotype G4 Italian Human Rotaviruses. J. Clin. Microbiol.
43: 1420-1425
[Abstract]
[Full Text]
-
Banyai, K., Gentsch, J. R., Schipp, R., Jakab, F., Bene, J., Melegh, B., Glass, R. I., Szucs, G.
(2004). Molecular epidemiology of human P[8],G9 rotaviruses in Hungary between 1998 and 2001. J Med Microbiol
53: 791-801
[Abstract]
[Full Text]
-
Page, N. A., Steele, A. D.
(2004). Antigenic and Genetic Characterization of Serotype G2 Human Rotavirus Strains from the African Continent. J. Clin. Microbiol.
42: 595-600
[Abstract]
[Full Text]
-
Banyai, K., Gentsch, J. R., Glass, R. I., Uj, M., Mihaly, I., Szucs, G.
(2004). Eight-Year Survey of Human Rotavirus Strains Demonstrates Circulation of Unusual G and P Types in Hungary. J. Clin. Microbiol.
42: 393-397
[Abstract]
[Full Text]
-
Esona, M. D, Armah, G. E., Geyer, A., Steele, A. D.
(2004). Detection of an Unusual Human Rotavirus Strain with G5P[8] Specificity in a Cameroonian Child with Diarrhea. J. Clin. Microbiol.
42: 441-444
[Abstract]
[Full Text]
-
Lovmar, L., Fock, C., Espinoza, F., Bucardo, F., Syvanen, A.-C., Bondeson, K.
(2003). Microarrays for Genotyping Human Group A Rotavirus by Multiplex Capture and Type-Specific Primer Extension. J. Clin. Microbiol.
41: 5153-5158
[Abstract]
[Full Text]
-
Laird, A. R., Gentsch, J. R., Nakagomi, T., Nakagomi, O., Glass, R. I.
(2003). Characterization of Serotype G9 Rotavirus Strains Isolated in the United States and India from 1993 to 2001. J. Clin. Microbiol.
41: 3100-3111
[Abstract]
[Full Text]
-
Das, S., Varghese, V., Chaudhury, S., Barman, P., Mahapatra, S., Kojima, K., Bhattacharya, S. K., Krishnan, T., Ratho, R. K., Chhotray, G. P., Phukan, A. C., Kobayashi, N., Naik, T. N.
(2003). Emergence of Novel Human Group A Rotavirus G12 Strains in India. J. Clin. Microbiol.
41: 2760-2762
[Abstract]
[Full Text]
-
Rahman, M., De Leener, K., Goegebuer, T., Wollants, E., Van der Donck, I., Hoovels, L. V., Van Ranst, M.
(2003). Genetic Characterization of a Novel, Naturally Occurring Recombinant Human G6P[6] Rotavirus. J. Clin. Microbiol.
41: 2088-2095
[Abstract]
[Full Text]
-
Cunliffe, N. A., Rogerson, S., Dove, W., Thindwa, B. D. M., Greensill, J., Kirkwood, C. D., Broadhead, R. L., Hart, C. A.
(2002). Detection and Characterization of Rotaviruses in Hospitalized Neonates in Blantyre, Malawi. J. Clin. Microbiol.
40: 1534-1537
[Abstract]
[Full Text]
-
O'Halloran, F., Lynch, M., Cryan, B., Fanning, S.
(2002). Application of Restriction Fragment Length Polymorphism Analysis of VP7-Encoding Genes: Fine Comparison of Irish and Global Rotavirus Isolates. J. Clin. Microbiol.
40: 524-531
[Abstract]
[Full Text]
-
Das, S., Sen, A., Uma, G., Varghese, V., Chaudhuri, S., Bhattacharya, S. K., Krishnan, T., Dutta, P., Dutta, D., Bhattacharya, M. K., Mitra, U., Kobayashi, N., Naik, T. N.
(2002). Genomic Diversity of Group A Rotavirus Strains Infecting Humans in Eastern India. J. Clin. Microbiol.
40: 146-149
[Abstract]
[Full Text]